Catherine L Overed-Sayer

Title: The Innovations of Catherine L Overed-Sayer

Introduction

Catherine L Overed-Sayer is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 2 patents to her name, her work focuses on innovative solutions for immune and inflammatory disorders.

Latest Patents

Catherine's latest patents include "Polynucleotides encoding IL33 antibodies and methods of using the same." This invention provides isolated IL-33 proteins, active fragments thereof, and antibodies against IL-33 proteins. Additionally, it outlines methods for modulating cytokine activity, which can be crucial for treating various immune and inflammatory disorders. Another patent she holds involves the IL33 form, including mutated forms of IL33, antibodies, assays, and methods of using the same.

Career Highlights

Catherine is currently associated with Medimmune Limited, where she continues to advance her research and development efforts. Her work has been instrumental in the field, contributing to the understanding and treatment of complex immune responses.

Collaborations

Catherine has collaborated with notable colleagues, including Emma Suzanne Cohen and David C Lowe. These partnerships have further enhanced her research capabilities and broadened the impact of her inventions.

Conclusion

Catherine L Overed-Sayer exemplifies the spirit of innovation in biotechnology. Her patents and ongoing research are paving the way for new treatments in the medical field.